Institute Of Hematology And Blood Transfusion — Clinical Trial Site

27 Registered trials

14 Currently recruiting

Organisation

Institute Of Hematology And Blood Transfusion

Location

Prague, Czechia

Identifier

ORG-100027339

Address

U Nemocnice 2094/1, Nove Mesto, 128 00, Czechia

Departments

#2012:Hematologie
1903:Oddělení buněčné terapie
2204: NA
2300, NA
6001
Ambulance
Center of Thrombosis and Hemostasis
Hematology
JIHeP
Klinicky usek
Klinický úsek - Ambulance, JIHeP a transplantační jednotka
N/A
NA
ÚHKT
UHT Praha , Centrum pro trombózu a hemostázu
Ústav hematologie a krevni transfuze
Ustav hematologie a krevni transfuze (#1)
Ústav hematologie a krevní transfuze, Klinický úsek

Clinical trials at this site (27)

Search interface

A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APP… Pending

2024-516570-30-00 Relapsed/refractory T-cell Acute Lymphoblastic Leukemia 4
Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL Pending

2025-522019-40-00 relapsed or refractory BCR::ABL1-positive (Philadelphia 9
A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t… Pending

2025-523555-66-00 Myelofibrosis 5
A Global Study Testing the New Drug Olverembatinib combined with chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Pos… Recruiting

2024-511496-14-00 Newly Diagnosed Philadelphia Chromosome-Positive Acute 5 2026-05-14
Studies testing Ziftomenib together with standard treatments in adults with newly diagnosed acute myeloid leukemia (AML) that has specific g… Recruiting

2025-521314-25-00 NPM1-m and KMT2A-r Acute Myeloid Leukemia 5 2026-03-19
A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft-Versus-Host Disease A… Recruiting

2024-518973-32-00 Chronic Graft-Versus-Host Disease 5 2025-07-03
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients with FLT3-ITD Negative AML Recruiting

2023-507936-20-00 Acute myeloid leukemia 5 2025-05-05
A 24-month study evaluating physical activity and joint health in patients 12 years and older, with severe haemophilia A treated once weekly… Recruiting

2022-500275-31-00 Haemophilia A 5 2023-06-20
A study to investigate the efficacy, safety, and pharmacokinetics of oral rilzabrutinib compared with placebo in participants 18 years of ag… Recruiting

2024-517972-39-00 Autoimmune haemolytic anaemia 5 2025-08-19
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Recruiting

2024-520154-38-00 Acute Myeloid Luekemia 5 2025-07-29
A study of elritercept to treat transfusion-dependent anemia due to very low, low, or intermediate risk myelodysplastic syndromes Recruiting

2024-516009-22-00 myelodysplastic neoplasms/syndromes (MDS) 5 2025-04-30
A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting

2024-515034-33-00 Mantle Cell Lymphoma 9 2025-03-05
CAR123 T cell treatment of relapsed/refractory hematologic malignancies. Recruiting

2022-503165-30-00 Relapsed/refractory CD123+ hematological malignancies: 1 2024-10-23
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis Recruiting

2023-504724-25-00 Primary Myelofibrosis 5 2024-10-16
Multi-cohort Study to Customize Ibrutinib Treatment Regimens for Patients with Previously Untreated Chronic Lymphocytic Leukemia TAILOR Recruiting

2023-504044-34-00 Untreated Chronic Lymphocytic Leukemia 4 2024-04-17
Asciminib Roll-over Study Recruiting

2023-507557-16-00 chronic myelogenous leukemia (CML) or Philadelphia Chro 5 2022-08-31
CART19 cells effects in patients with relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma. Recruiting

2024-510815-30-00 Relapsed/refractory CD19+ Acute Lymphoblastic Leukaemia 1 2021-06-02
A study to test an oral medicine, belumosudil, in combination with corticosteroids in participants at least 12 years of age with newly diagn… Ended

2023-505394-32-00 chronic graft versus host disease 5 2025-02-06
A Phase 3b Study of BMS-986346 in Lower-risk Myelodysplastic Syndrome Participants Ended

2023-504541-31-00 Myelodysplastic syndrome 5 2024-03-06
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With N… Ended

2024-510947-71-00 Chronic Myeloid Leukemia 5 2022-11-21
A Study Evaluating The Safety, Pharmacokinetics, and Efficacy Of Crovalimab Versus Eculizumab In Participants With Paroxysmal Nocturnal Hemo… Ended

2023-506526-37-00 Paroxysmal Nocturnal Hemoglobinuria (PNH) 5 2021-03-17
Double-Blind study comparing venetoclax and azacitidine versus placebo and azacitidine in patients that are newly diagnosed with Higher-Risk… Ended

2023-507153-16-00 Higher-Risk Myelodysplastic Syndrome 5 2020-11-18
A Prospective Phase II Clinical Trial Evaluating the Efficacy and the Safety of Tyrosine Kinase Inhibitors Withdrawal After a Previous Two-s… Ended

2024-514592-17-00 chronic myeloid leukemia 4 2020-06-16
An 18-month study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa Ended

2022-502921-16-00 Hemophilia A and B 6 2023-07-21